when to change over to long acting pain medications for the treatment of chronic pain

If there is no adverse event in this 72 hour period, titrate the dosage of long-acting opioid upward to increase pain control over the next six to twelve weeks. Allow the patient to continue HCA or other short-acting opioids on an as-needed basis for breakthrough pain or flares.

Full Answer

How long does it take for opioid pain medication to work?

By this method, severe chronic pain patients will, over a period of six to twelve weeks, settle on a quite stable regimen of a combination of long and short-acting opioids and ancillary medications. Patients treated by this method achieve significantly better pain control and enhance their physical, mental, social, and vocational status.

When should pain patients transition to long-acting opioids?

While most pain patients are initially treated with short-acting opioids, severe unremitting pain involving biological manifestations requires transitioning to long-acting opioids—but not on the basis of equivalency tables.

What is opioid therapy for chronic pain?

Opioid Treatment for Chronic Pain Opioid therapy is the mainstay approach for the treatment of moderate to severe pain associated with cancer or other serious medical illnesses (Patt & Burton, 1998; World Health Organization, 1996).

Do opioid prescribing patterns vary by patients with chronic pain?

It is generally acknowledged that there is a wide degree of variance in the prescribing patterns of opioids for chronic pain (Lin, Alfandre, & Moore, 2007; Trescot et al., 2006).

When prescribing opioids for acute pain How long is often sufficient duration of therapy?

Three days or less will often be sufficient; more than seven days will rarely be needed. Clinicians should evaluate benefits and harms with patients within 1 to 4 weeks of starting opioid therapy for chronic pain or of dose escalation.

How do you transition to long acting opioids?

Start a low dose of long-acting opioid. (See Table 6.) Leave patient at the low dose of long-acting opioid for at least 72-hours. Titrate the long-acting opioid dosage upward over several days or weeks until there is good pain control without sedation or impairment.

What is the preferred treatment plan for chronic pain?

1. Nonpharmacologic therapy and nonopioid pharmacologic therapy are preferred for chronic pain. Clinicians should consider opioid therapy only if expected benefits for both pain and function are anticipated to outweigh risks to the patient.

What is considered prolonged use of opioids?

Corresponding to the Centers for Disease Control and Prevention definition of chronic pain as lasting longer than 3 months,19 long-term use was defined as receiving an opioid on most days for a 90-day period, measured as 45 or more prescription days in 90 days after injury.

How do I convert oxycodone to OxyContin?

Conversion from Other Oral Oxycodone Formulations to OXYCONTIN If switching from other oral oxycodone formulations to OXYCONTIN, administer one half of the patient's total daily oral oxycodone dose as OXYCONTIN every 12 hours.

How do you titrate opioids?

Titrate the dose to achieve the best analgesia with the fewest side effects. When titrating, increase the regular opioid dose by about 25%. Increase the breakthrough dose at the same time, using the guideline of 10% of the total daily dose given every 1 hour as needed.

Why is treating chronic pain so difficult?

“Treating chronic pain is challenging because of the complex nature of pain and unique nature of each sufferer. Therefore, a customized approach is required for best results.

What is the strongest non opioid pain medicine?

Many patients find that ibuprofen, a non-steroidal anti-inflammatory (NSAID), is all they need. In cases where ibuprofen alone is not enough, studies show that a combination of ibuprofen (Advil, Motrin) and acetaminophen (Tylenol) actually works better than opioids following dental surgery.

What is the time frame defining when pain becomes chronic?

Pain can be acute, meaning new, subacute, lasting for a few weeks or months, and chronic, when it lasts for more than 3 months.

Can you recover from long term opioid use?

Evidence-based approaches to treating opioid addiction include medications and combining medications with behavioral therapy. A recovery plan that includes medication for opioid addiction increases the chance of success.

How long is long term use?

Long-term use was defined as continuous use lasting 180 days or longer.

Do opioids make chronic pain worse?

Opioids can make some types of chronic pain worse. For instance, they can make migraines worse and more frequent. And they can make pain in your lower back last longer. Over time, your body gets used to the effect of opioids.

How long does it take for a chronic pain patient to settle on opioids?

By this method, severe chronic pain patients will, over a period of six to twelve weeks, settle on a quite stable regimen of a combination of long and short-acting opioids and ancillary medications. Patients treated by this method achieve significantly better pain control and enhance their physical, mental, social, and vocational status. I have now followed 20 of these patients for over 20 years.

How to initiate long acting opioids?

Rather than stop HCA, meperidine, or other short-acting opioid, merely continue the short-acting and add a low dose of long-acting opioid to the regimen. Leave the patient on this low dose for 72 or more hours to insure that there is no drug interaction, over-sedation, drug sensitivity, or allergic reaction. If there is no adverse event in this 72 hour period, titrate the dosage of long-acting opioid upward to increase pain control over the next six to twelve weeks. Allow the patient to continue HCA or other short-acting opioids on an as-needed basis for breakthrough pain or flares. The patient is instructed to only reduce or stop their short-acting opioids and ancillary medications on a schedule that provides them maximal pain relief.

How long does it take for opioids to raise?

Once this period has passed, the dosage of long-acting opioid can be progressively raised over the next six to twelve weeks. As the dosage is raised, the patient and practitioner can mutually determine the need and dosage of short-acting opioid for breakthrough, flare pain. The same goes for ancillary medications.

Why do we need to titrate opioids?

Long-acting opioids must be initiated and titrated with great caution to avoid side-effects such as sedation and deaths due to overdose or drug interactions (see Table 7). It is essential that all parties who surround the patient including family, friends, pharmacist, and clergy, among others, be aware that the initiation and maintenance of long-acting opioid therapy likely represents the presence of intractable, life-time pain. Long-acting opioid therapy should be viewed as a serious procedure that will last indefinitely. Certain physicians should avoid long-acting opioids and refer the patient to another physician unless they can structure their practice time to properly educate, titrate, and monitor the patient for adverse complications and maximal pain relief.

How to know if you need an opioid?

A more specific way to identify patients in need of a long-acting opioid is to search for evidence that pain is adversely affecting some of the body’s normal biologic functions. Invariably these patients will have persistent or a baseline pain. Upon inquiry, the patient will state that their pain is constantly present except during sleep. Patients relate that they have diminished appetite, sleep, mental concentration, and libido. They stop social contacts and are often bed- or house-bound. Particularly, during pain flares or episodes of breakthrough pain, they demonstrate pulse rates about 84 per minute and oftentimes over 120 per minute. Blood pressure may be continuously or episodically elevated. If tested, the patient will almost always demonstrate hormone abnormalities of the pituitary, adrenal, or thyroid glands. 3 The presence of multiple biologic abnormalities (e.g. “biologic pain syndrome”) is a strong indication for a long-acting opioid.

What are the two types of chronic pain?

There are two basic types of chronic pain: intermittent and constant. Intermittent pain is the most common form of chronic pain and encompasses headaches and musculo-skeletal disorders. The constant form is permanent and is characterized by existing biological manifestation (e.g. neurologic defect) that produces constant pain. While some flares or breakthrough episodes appear to be precipitated by such events as intentional movement, stress, or concomitant illness, others have no discernable etiology. To control constant pain caused by permanent neurologic defect, a critical blood level of opioid must be maintained at all times including sleep-time. A physician who attempts to control constant, baseline pain with short-acting opioids may witness their patient escalating their dosage—often to unsafe levels. In addition, patients may attempt to use ancillary medications including benzodiazepines, muscle relaxants, anti-inflammatory agents, anti-depressants, and even alcohol or illegal drugs in an effort to control their pain. The clinical picture may falsely appear as if the patient is randomly abusing medication when, in reality, the patient needs a long-acting opioid to suppress the baseline pain. Once baseline pain is adequately-controlled, one can then reduce the use of short-acting opioids and ancillary medications. Patients who compulsively seek relief in the face of poorly-controlled pain are referred to as pseudoaddicts.

What is the most commonly prescribed drug?

Hydrocodone-acetaminophen compounds (HCA) and other short-acting opioids are now among the most commonly prescribed drugs. 1,2 This is indeed a tribute to physicians who have elevated treatment of pain problems in their practices to a position of prime importance—as it should be.

Why is sustained analgesia important?

Providing sustained analgesia is an important aspect of therapy, and medications should be administered on an around-the-clock basis, because regular administration of doses maintains a constant level of drug in the body and helps prevent recurrence of pain.

Can opioids be used for pain?

It has been suggested that opioid therapy can be used effectively to treat noncancer pain in a subset of patients [26], and this is becoming more acceptable [3]. Providing sustained analgesia is an important aspect of therapy, and medications should be administered on an around-the-clock basis, because regular administration of doses maintains a constant level of drug in the body and helps prevent recurrence of pain. Ideal treatment for persistent pain is a long-acting opioid administered around the clock to prevent baseline pain, with the use of short-acting opioids as supplemental agents for breakthrough pain. Controlled-release formulations can lessen the inconvenience associated with around-the-clock administration of short-acting opioids. Sustained analgesia also can be achieved with transdermal fentanyl, which combines a strong opioid with a 72-hour release profile and the benefits of a parenteral route, avoiding first-pass metabolism. Controlled-release formulations of morphine and oxycodone are available in the United States, and hydromorphone preparations are being reviewed for approval. Clinical experience with these formulations and transdermal fentanyl indicates that these agents are equally effective in controlling pain. Studies have demonstrated improved quality of life with the transdermal route and with controlled-release morphine and oxycodone. Because of patch reapplication every 72 hours, the transdermal route also enhances compliance. Use of an opioid without the need for oral or intravenous administration and the opportunity to improve compliance are among the advantages of the transdermal route in clinical practice. The nurse has an important role in the management of patients receiving long-acting opioids for chronic noncancer pain, Facilitation of the conversion from short-acting to long-acting opioids may be the initial step. Individualization of therapy to determine which route and product best suits the patient's needs and lifestyle can be accomplished through a comprehensive nursing assessment. Titration of dose along with institution of a short-acting opioid for break-through pain may require frequent interventions that a nurse familiar with the patient can provide. Prevention and management of opioid-related adverse events are essential for effective opioid therapy. Providing patient and family education regarding administration, monitoring, and management of opioid therapy is an important nursing role. Lastly, documentation of pain level, functional status, and opioid-related adverse events is required for each contact with the patient, to make this information available to all who assist in the management of the patient's pain. Chronic noncancer pain is an experience that affects all aspects of a patient's life. Effective pain management with long-acting opioids may help the patient to focus on the positive aspects of life, decreasing the focus on pain.

Why is it important to review all medications and health problems with chronic pain patients?

It is important to review all medications and health problems with your chronic pain patients. Being informed about the specific adverse effects associated with pain medications can increase the chances of avoiding severe health problems, and lead to a better treatment outcome for their pain.

Why are pain medications important?

Pain medications provide an important component of most treatment plans intended to relieve suffering and enhance the quality of lives for many patients. As with most other medical treatments, they may also often have significant adverse effects. In some cases, especially with long-term use, a pain medication may cause more harm than good.

What is adjuvant analgesic?

Adjuvant analgesics are generally non-opioid medications used for pain relief which may be primarily used for other health problems , and they are usually prescribed with other pain medications. Two examples of adjuvant analgesics are anticonvulsants and antidepressants. They are generally used as part of a treatment plan for neuropathic pain. Adverse effects of these medications may include sedation and cognitive impairment and help with sleep. Another type of adjuvant analgesic that may be used is local anesthetic agents, such as topical lidocaine 5% for the treatment of post-herpetic neuralgia.

What is the best pain medication for mild to moderate pain?

Acetaminophen is one of the most popular OTC pain medications that are commonly prescribed for mild to moderate pain. It is frequently used as an analgesic and antipyretic, and it is considered the first-line pain medication for many conditions, especially in people for whom NSAIDs are contraindicated.

What is the best pain medication?

Nonsteroidal anti-inflammatory drugs (NSAIDs) are probably the most popular OTC pain medications. While some strengths are available by prescription, they are often easily obtained without a prescription. Some examples of commonly used NSAIDS are aspirin, ibuprofen, and naproxen. One of the key benefits of NSAIDs is that they are used to reduce both pain and inflammation. Most types of chronic pain are thought to have some degree of an inflammatory component.

What are the adverse effects of opioids?

Examples of opioids are morphine, hydrocodone, oxycodone, oxymorphone, and codeine. Three common adverse effects of opioids are constipation, nausea and respiratory depression.

Why is acetaminophen dangerous?

Unfortunately, unintentional overdose occurs frequently because patients are unaware of combining medications with each other that both contain acetaminophen. Signs and symptoms of liver damage can include abdominal pain, yellowing of the skin or eyes, and nausea or vomiting.

What are the effects of chronic pain in the elderly?

Chronic pain in the elderly is associated with an increased incidence of adverse outcomes, including functional impairment, falls, depression, and sleep disturbances. Pain management in older persons differs significantly from that in younger persons. Concomitant chronic illnesses make pain evaluation and treatment more difficult in the elderly. Also, older people respond differently to various therapies, usually with lesser efficacy and more severe adverse reactions, including additional risks of polypharmacy and addictions. In addition to this, the majority of elderly living in nursing homes have some degree of cognitive impairment, which has an impact on their ability to report pain resulting in inadequate pain assessment and management [7]. There is a lack of evidence-based guidelines for the treatment of chronic pain in the elderly as studies tend to focus more on younger adults. However, in the recent past, there has been an increase in the number of studies focused primarily on pain control in the elderly.

What are the best ways to treat chronic pain in the elderly?

Various treatment options are available for chronic pain management in the elderly including either pharmacological or non-pharmacological measures or both combined. A comprehensive approach to dealing with common sequelae such as depression, isolation, and physical disability is considered effective. Non-pharmacological measures are considered particularly important in elderly patients as they have a lower frequency of adverse reactions compared with pharmacologic approaches and their benefit is usually enhanced when combined with drug strategies. Effective non-pharmacological approaches include physical therapy, cognitive behavioral therapy, and most importantly, patient and caregiver education interventions [12, 13], while pharmacological treatment modalities include non-opioid and opioid medications, pain modulating drugs, topical agents, and other newer therapies.

What are the risks of taking opioids in the elderly?

A prerequisite before initiation of opioid therapy is the evaluation of risk versus benefit in view of its adverse effects, and efforts to reduce risks are mandatory. Administration of opioids in the elderly is done on a trial basis to titrate the effective dose reaching the therapeutic goal with minimal adverse effects, starting with the lowest possible dose and gradual titration. Respiratory depression is one of the major concerns of opioid therapy, though tolerance to this effect develops rapidly. Respiratory depression is particularly common in patients who increase their doses rapidly, patients using drugs like methadone with variable pharmacokinetics, patients with concomitant use of drugs like benzodiazepines or barbiturates.  Elderly patients in particular with hepatic and renal dysfunction are at increased risk due to resultant drug accumulation, which warrants regular monitoring of parameters like glomerular filtration and dose adjustments [30, 31]. With due course of time, tolerance develops to the majority of the side effects of opioids (except constipation due to gastric hypomotility) like respiratory depression, sedation, nausea, and vomiting. Until the development of tolerance, patients are managed with combined administration of antiemetics and usage of assistive devices.  Complications of long-term usage of opioids include suppressed production of pituitary, gonadal, hypothalamic, and adrenal hormones manifesting as depression, fatigue, and decreased libido [1]. With prolonged therapy, opioid abuse is another major concern. Every patient should be assessed for risk factors related to the potential abuse with available tools like opioid Risk Tool (ORT) and the SOAPP-R (revised Screener and Opioid Assessment for Patients with Pain) [32]. Although clinicians must remain vigilant about the possibility of misuse or abuse of opioid agents in all patients, older age is generally associated with a relatively lower risk for opioid misuse and abuse [33].

What is the best NSAID for osteoarthritis?

Topical NSAIDs: Topical NSAIDs therapy comprises an important alternative to oral NSAIDs in the elderly because of its rare systemic side effects and very few cutaneous effects like rash or pruritis at the site of application. Topical NSAIDs are often used for knee or hand osteoarthritis (OA) related pain. Evidence from a recent randomized controlled trial showed the comparable efficacy of topical diclofenac sodium with that of oral NSAIDs in the treatment of knee osteoarthritis with fewer adverse effects [23]. This is because of increased delivery of drug to adjacent synovium without much systemic absorption. In the United States, there are two approved topical NSAID formulations for OA: diclofenac sodium topical solution 1.5% in 45.5% dimethyl sulfoxide solution and diclofenac sodium 1% gel. Another category of drugs are rubefacients, which include salicylate-containing drugs like trolamine salicylate or methyl salicylate that act by counter-irritation, but they have a lesser effect on chronic pain control compared to topical NSAIDs and increased risk of salicylate toxicity [24].

What is the best treatment for neuropathic pain?

Anticonvulsants: Antiepileptic drugs such as carbamazepine, gabapentin, and pregabalin are mainly used for neuropathic pain. In elderly patients with renal impairment, dose adjustment of gabapentin and pregabalin is required. Carbamazepine currently is the first line therapy for neuralgia. Gabapentin and pregabalin are recommended to be taken in short courses (two to four months) for certain types of neuropathic pain including diabetic neuropathy, central neuropathic pain after spinal cord injury, postherpetic neuralgia, and fibromyalgia. A meta-analysis study assessing 300 mg of pregabalin daily for neuropathic pain showed 50% reduction in pain [34]. Gabapentin dosage must be carefully titrated starting with 100-300 mg daily, up to a maximum dose of 3600 mg [35].

What is the most commonly used medication for elderly people?

Multiple comorbidities and the risk of polypharmacy in the elderly make it a challenge to determine the appropriate drug, dosage, and maintenance of therapy. Opioids are the most commonly used agents for this purpose in the elderly. The aim of this article is to discuss both the current well-established therapies used for managing chronic pain in the elderly and also the emerging newer therapies.

Why do elderly people have chronic pain?

Musculoskeletal disorders such as degenerative spine and arthritic conditions are the most common cause of chronic pain in the elderly. Other common causes of significance include neuropathic pain, ischemic pain, and pain due to cancer as well as its treatment [6]. Among elderly women, there is a high prevalence of vertebral compression fractures causing pain and discomfort.

How long does chronic pain last?

Chronic pain has been described as pain that has persisted for at least 1 month following the usual healing time of an acute injury, pain that occurs in association with a nonhealing lesion, or pain that recurs frequently over a period of months. In most clinical and research reports, chronic pain is typically defined as pain that has persisted for at least 3 months ( Verhaak, Kerssens, Dekker, Sorbi, & Sensing, 1998 ).

What are the influences of chronic pain?

Chronic pain also is influenced by psychosocial and psychiatric disturbances, such as cultural influences, social support, comorbid mood disorder, and drug abuse ( Gatchel, Peng, Peters, Fuchs & Turk, 2007 ). Classic studies of pain behavior indicate that cultural differences in the beliefs and attitudes towards pain (e.g., Zbrowski, 1969) and the social/environmental context of the pain (e.g., Beecher, 1959 ) have a significant impact on pain behaviors.

What is tolerance to opioids?

According to the consensus document, tolerance is defined as a decreased subjective and objective effect of the same amount of opioids used over time, which concomitantly requires an increasing amount of the drug to achieve the same effect. Although tolerance to most of the side effects of opioids (e.g., respiratory depression, sedation, nausea) does appear to occur routinely, there is less evidence for clinically significant tolerance to opioids– analgesic effects ( Collett, 1998; Portenoy et al., 2004 ). For example, there are numerous studies that have demonstrated stable opioid dosing for the treatment of chronic pain (e.g., Breitbart, et al., 1998; Portenoy et al., 2007) and methadone maintenance for the treatment of opioid dependence (addiction) for extended periods ( Strain and Stitzer, 2006 ). However, despite the observation that tolerance to the analgesic effects of opioid drugs may be an uncommon primary cause of declining analgesic effects in the clinical setting, there are reports (based on experimental studies) that some patients will experience worsening of their pain in the face of dose escalation ( Ballantyne, 2006 ). It has been speculated that some of these patients are not experiencing more pain because of changes related to nociception (e.g. progression of a tissue-injuring process), but rather, may be manifesting an increase in pain as a result of the opioid-induced neurophysiological changes associated with central sensitization of neurons that have been demonstrated in preclinical models and designated opioid-induced hyperalgesia ( Mao, 2002; Angst & Clark, 2006 ). Analgesic tolerance and opioid-induced hyperalgesia are related phenomena, and just as the clinical impact of tolerance remains uncertain in most situations, the extent to which opioid-induced hyperalgesia is the cause of refractory or progressive pain remains to be more fully investigated. Physical dependence represents a characteristic set of signs and symptoms (opioid withdrawal) that occur with the abrupt cessation of an opioid (or rapid dose reduction and/or administration of an opioid antagonist). Physical dependence symptoms typically abate when an opioid is tapered under medical supervision. Unlike tolerance and physical dependence which appear to be predictable time-limited drug effects, addiction is a chronic disease that “represents an idiosyncratic adverse reaction in biologically and psychosocially vulnerable individuals” ( ASAM, 2001 ).

What is the most effective pain medication?

Opioids have been regarded for millennia as among the most effective drugs for the treatment of pain. Their use in the management of acute severe pain and chronic pain related to advanced medical illness is considered the standard of care in most of the world. In contrast, the long-term administration of an opioid for the treatment of chronic non-cancer pain continues to be controversial. Concerns related to effectiveness, safety, and abuse liability have evolved over decades, sometimes driving a more restrictive perspective and sometimes leading to a greater willingness to endorse this treatment. The past several decades in the United States have been characterized by attitudes that have shifted repeatedly in response to clinical and epidemiological observations, and events in the legal and regulatory communities. The interface between the legitimate medical use of opioids to provide analgesia and the phenomena associated with abuse and addiction continues to challenge the clinical community, leading to uncertainty about the appropriate role of these drugs in the treatment of pain. This narrative review briefly describes the neurobiology of opioids and then focuses on the complex issues at this interface between analgesia and abuse, including terminology, clinical challenges, and the potential for new agents, such as buprenorphine, to influence practice.

How many people have chronic pain?

The prevalence of chronic pain in the general population is believed to be quite high, although published reports have varied greatly. Cautious cross-national estimates of chronic pain range from 10% ( Verhaak et al., 1998) to close to 20% ( Gureje, Simon, & Von Korff, 2001 ), which would represent 30 to 60 million Americans. A national survey of 35,000 households in the US, conducted in 1998, estimated that the prevalence among adults of moderate to severe non-cancer chronic pain was 9% ( American Pain Society, 1999 ). A large survey (N=18,980) of general populations across several European countries reported that the prevalence for chronic painful physical conditions was 17.1% ( Ohayon & Schatzberg, 2003 ).

How prevalent is substance abuse in chronic pain?

One 1992 literature review found only seven studies that utilized acceptable diagnostic criteria and reported that estimates of substance use disorders among chronic pain patients ranged from 3.2% – 18.9% ( Fishbain, Rosomoff, & Rosomoff, 1992 ). A Swedish study of 414 chronic pain patients reported that 32.8% were diagnosed with a substance use disorder ( Hoffmann, Olofsson, Salen, & Wickstrom, 1995 ). In two US studies, 43 to 45% of chronic pain patients reported aberrant drug-related behavior; the proportion with diagnosable substance use disorder is unknown ( Katz et al., 2003 ; Passik et al., 2004 ). All these studies evaluated patients referred to pain clinics and may overstate the prevalence of substance abuse in the overall population with chronic pain.

Can opioids help with CNMP?

This consensus, however, has received little support in the literature. Systematic reviews on the use of opioids for diverse CNMP disorders report only modest evidence for the efficacy of this treatment ( Trescot et al., 2006; 2008 ). For example, a review of 15 double-blind, randomized placebo-controlled trials reported a mean decrease in pain intensity of approximately 30% and a drop-out rate of 56% only three of eight studies that assessed functional disturbance found improvement ( Kalso, Edwards, Moore, & McQuay, 2004 ). A meta-analysis of 41 randomized trials involving 6,019 patients found reductions in pain severity and improvement in functional outcomes when opioids were compared with placebo ( Furlan, Sandoval, Mailis-Gagnon, & Tunks, 2006 ). Among the 8 studies that compared opioids with non-opioid pain medication, the six studies that included so-called “weak” opioids (e.g., codeine, tramadol) did not demonstrate efficacy, while the two that included the so-called “strong” opioids (morphine, oxycodone) were associated with significant decreases in pain severity. The standardized mean difference (SMD) between opioid and comparison groups, although statistically significant, tended to be stronger when opioids were compared with placebo (SMD = 0.60) than when strong opioids where compared with non-opioid pain medications (SMD = 0.31). Other reviews have also found favorable evidence that opioid treatment for CNMP leads to reductions in pain severity, although evidence for increase in function is absent or less robust ( Chou, Clark, & Helfand, 2003; Eisenberg, McNicol, & Carr, 2005 ). Little or no support for the efficacy of opioid treatment was reported in two systematic reviews of chronic back pain ( Deshpande, Furlan, Mailis-Gagnon, Atlas, & Turk, 2007; Martell, et al., 2007 ). Because patients with a history of substance abuse typically are excluded from these studies, they provide no guidance whatsoever about the effectiveness of opioids in these populations.

What is chronic pain?

Chronic pain is pain that persists or grows worse over a long period of time.

Does a drug have multiple schedules?

The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.

Is there a lack of accepted safety for use under medical supervision?

Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.

Is abuse a low potential for abuse relative to those in Schedule 4?

Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.

Nonsteroidal Anti-Inflammatory Drugs

• NSAIDsare most effective for mild to moderate pain that's accompanied by swelling and inflammation. These drugs are commonly used for arthritis and pain resulting from muscle sprains, strains, back and neck injuries, or menstrual cramps. 1. Generic (brand) names.Ibuprofe…

See more on mayoclinic.org

COX-2 Inhibitors

Antidepressants and Anti-Seizure Medications

Opioids